Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
29.96
+0.34 (1.15%)
Mar 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 29.64 - 30.12
52 week 19.25 - 30.12
Open 29.64
Vol / Avg. 985,504.00/914,565.00
Mkt cap 2.91B
P/E 27.69
Div/yield     -
EPS 1.08
Shares 72.05M
Beta 0.64
Inst. own 97%

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 16.03% 18.50%
Operating margin 23.56% 27.33%
EBITD margin - 35.09%
Return on average assets 10.65% 11.85%
Return on average equity 11.87% 13.49%
Employees 1,400 -
CDP Score - -

Address

2560 General Armistead Ave
AUDUBON, PA 19403-5214
United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. Its products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Company's Disruptive Technology products include motion preservation offerings, such as SECURE-C and SECURE-CR; MONUMENT, an interbody implant for the reduction of a grade 1 spondylolisthesis; KINEX and SIGNIFY bone void fillers, and CONDUCT ceramic-collagen, and SHIELD and AFFIRM products that allow for the treatment of vertebral compression fractures.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 49
Anthony L. Williams President
Age: 45
Daniel T. Scavilla Chief Financial Officer, Senior Vice President
Age: 51
David M. Demski Director, Group President, Emerging Technologies
Age: 58
Andrew Brett Murphy Group President, Commercial Operations
Age: 52
Eric Ian Schwartz Senior Vice President, General Counsel
Age: 43
David D. Davidar Director
Age: 49
Daniel T. Lemaitre Independent Director
Age: 62
Robert W. Liptak CPA Independent Director
Age: 52
Ann D. Rhoads Independent Director
Age: 50